PKI 14-22 amide, myristoylated

PKI (14-22) amide (myristoylated) is cell-permeable protein kinase A inhibitor. The non-myristoylated type of this peptide is a highly specific inhibitor of cAMP-dependent protein kinase (PKA), N-terminus is myristoylated to increase cell membrane permeability. It is usually used to study PKA in cellular systems in-vitro.

Online Inquiry

CAT#R0879
CAS201422-03-9
Synonyms/AliasProtein kinase inhibitor-(14-22)-amide, myristoylated
M.F/FormulaC53H100N20O12
M.W/Mr.1209.5
SequenceMyr-GRTGRRNAI-NH2
Labeling TargetProtein kinase A
AppearanceWhite lyophilised solid
Purity>98% (or refer to the Certificate of Analysis)
ActivityInhibitor
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

 Dalbavancin, marketed under the brand name of Dalvance, is a new semi-synthetic glycopeptide antibiotic for anti ...

Trimetazidine is a partial fatty acid oxidation inhibitor that inhibits 3-ketoacyl CoA thiolase, one of the enzymes of fatty ...

 Studies on the binding affinities of darifenacin hydrobromide and human muscarinic receptor subtypes show strong ...

 NoxA1ds is derived from a peptide whose structure is based on a short sequence of an essential Nox subunit. It b ...

 Teriparatide is a human parathyroid hormone analog with the same structure as the N-terminal 34 amino acid seque ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.